Showing results (731-740 of 1,267) with videos related to

Sort By:
Pageof 127
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2024
An integrated structural model of the DNA damage-responsive H3K4me3 binding WDR76:SPIN1 complex with the nucleosomeXingyu Liu, Ying Zhang, Zhihui Wen, et al.
Cancer|August 1, 1996
Phase II evaluation of topotecan for pediatric central nervous system tumorsS M Blaney, P C Phillips, R J Packer, et al.
Allergy|April 10, 2016
Self-medication of anaphylactic reactions due to Hymenoptera stings-an EAACI Task Force Consensus StatementM B Bilò, E Cichocka-Jarosz, R Pumphrey, et al.
American Journal of Respiratory and Critical Care Medicine|May 9, 2025
Lipid Ratios for Diagnosis and Prognosis of Pulmonary HypertensionNatalie Bordag, Bence Miklos Nagy, Elmar Zügner, et al.
Deutsche Medizinische Wochenschrift (1946)|September 24, 2010
[Pulmonary hypertension due to chronic lung disease. Recommendations of the Cologne Consensus Conference 2010]M M Hoeper, S Andreas, A Bastian, et al.
Pneumologie (Stuttgart, Germany)|December 25, 2010
[Pulmonary hypertension due to chronic lung disease. Recommendations of the Cologne Consensus Conference 2010]M M Hoeper, S Andreas, A Bastian, et al.
International Journal of Cardiology|January 7, 2012
Pulmonary hypertension due to chronic lung disease: updated Recommendations of the Cologne Consensus Conference 2011Marius M Hoeper, Stefan Andreas, Andreas Bastian, et al.
MMWR. Morbidity and Mortality Weekly Report|June 26, 2020
Potential Indirect Effects of the COVID-19 Pandemic on Use of Emergency Departments for Acute Life-Threatening Conditions - United States, January-May 2020Samantha J Lange, Matthew D Ritchey, Alyson B Goodman, et al.
Drugs - Real World Outcomes|January 12, 2026
Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)Pilar Escribano Subias, Murali M Chakinala, Kelly M Chin, et al.
The European Respiratory Journal|October 20, 2018
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patientsMarion Delcroix, Gerd Staehler, Henning Gall, et al.
Pageof 127